Patents Assigned to University
-
Publication number: 20170044282Abstract: The invention relates to a method for producing functionalised monomers, the method comprising: a) providing a starting material selected from terpenes and terpenoids; b) forming a derivative of the starting material by incorporation of a hydroxyl group; c) esterifying the hydroxyl group of the derivative to introduce a moiety containing a vinyl group, so as to produce a functionalised monomer. The functionalised monomer can be polymerised to obtain a bio-derived polymer.Type: ApplicationFiled: April 22, 2015Publication date: February 16, 2017Applicant: The University of NottinghamInventors: Steven Howdle, Robert Stockman, Marina Fuentes, Jose Souto, Dominika Regentova, Derek Irvine
-
Publication number: 20170047520Abstract: The invention provides novel materials, methods and designs to enable improved power conversion efficiencies of organic photovoltaics (OPVs). In particular, the invention provides novel materials and interlayers for polymer-based solar cells. Novel functional fullerene-based interlayers are disclosed that enable high efficiency devices in conjunction with numerous active layer and electrode materials.Type: ApplicationFiled: May 6, 2015Publication date: February 16, 2017Applicant: University of MassachusettsInventors: Zachariah Page, Yao Liu, Thomas P. Russell, Todd Emrick
-
Publication number: 20170046601Abstract: Method for determining one or more viewer affects evoked from visual content using visual sentiment analysis using a correlation model including a plurality of publisher affect concepts correlated with a plurality of viewer affect concepts includes detecting one or more of the plurality of publisher affect concepts present in selected visual content, and determining, using the correlation model, one or more of the plurality of viewer affect concepts corresponding to the one or more of the detected publisher affect concepts. A method for determining one or more visual content to evoke one or more viewer affects using visual sentiment analysis is also provided.Type: ApplicationFiled: July 27, 2016Publication date: February 16, 2017Applicant: The Trustees Of Columbia University In The City Of New YorkInventors: Shih-Fu Chang, Yan-Ying Chen, Tao Chen
-
Publication number: 20170043166Abstract: Sensory information can be delivered to a subject mammal, for example, for restoring a sense of cutaneous touch and limb motion to the subject mammal. A biomimetic electrical signal is generated based on (a) a stimulation reference signal applied to a somatosensory region of a nervous system of a reference mammal, (b) a stimulated-response signal acquired from a sensory cortex of the reference mammal in response to application of the stimulation reference signal to the thalamic nucleus, and (c) a natural-response signal acquired from the sensory cortex in response to peripheral touch stimuli and/or peripheral nerve stimulation of the reference mammal. The biomimetic electrical signal is applied to a somatosensory region of a nervous system of the subject mammal to induce an activation response, in a sensory cortex of the subject mammal.Type: ApplicationFiled: April 14, 2015Publication date: February 16, 2017Applicant: Research Foundation for State University of New York (The)Inventors: John S. CHOI, Joseph T. FRANCIS
-
Publication number: 20170043038Abstract: The present invention is directed to reagents useful for generating immune responses to Mycobacterium tuberculosis and for diagnosing infection and disease in a subject that has been exposed to M. tuberculosis.Type: ApplicationFiled: October 27, 2016Publication date: February 16, 2017Applicant: Rutgers, The State University of New JerseyInventor: Maria Laura Gennaro
-
Publication number: 20170045272Abstract: A turbo-compression cooling system includes a power cycle and a cooling cycle coupled one to the other. The power cycle implements a waste heat waste heat exchanger configured to evaporate a first working fluid and a turbine configured to receive the evaporated working fluid. The turbine is configured to rotate as the first working fluid expands to a lower pressure. A condenser condenses the first working fluid to a saturated liquid and a pump pumps the saturated liquid to the waste heat waste heat exchanger. The cooling cycle implements a compressor increasing the pressure of a second working fluid, a condenser condensing the second working fluid to a saturated liquid upon exiting the compressor, an expansion valve expanding the second working fluid to a lower pressure, and an evaporator rejecting heat from a circulating fluid to the second working fluid, thereby cooling the circulating fluid.Type: ApplicationFiled: August 11, 2016Publication date: February 16, 2017Applicant: Colorado State University Research FoundationInventors: Todd M. Bandhauer, Torben P. Grumstrup
-
Publication number: 20170044173Abstract: The invention provides a method of treating drug and alcohol abuse, depression, anxiety, or a compulsive disorder in a subject comprising administering to the subject a compound having formula 2: or a pharmaceutically acceptable salt or solvate thereof, wherein R, R1, R2, R3, R4, R5, and X are as defined in the specification.Type: ApplicationFiled: October 27, 2016Publication date: February 16, 2017Applicant: The University of BathInventors: John LEWIS, Stephen Husbands
-
Publication number: 20170042717Abstract: Active wearable body brace embodiments provide selectable conformation control of the interface between the trunk of a human subject and the brace, which conformation may be varied over time and responsively to feedback and an updateable prescription. Further active wearable body brace embodiments provide selectable movement control of the interface between the trunk of a human subject and the brace with up to six degrees of freedom between elements to allow a controller to implement operations such as muscle challenges, active support, and passive-like support where actuators mimic springs. Further embodiments may also provide detection functions such as quantifying muscle weakness. The features of these embodiments may be combined in various ways to provide still further embodiments.Type: ApplicationFiled: April 24, 2015Publication date: February 16, 2017Applicant: The Trustees of Columbia University in the City of New YorkInventors: Sunil K. AGRAWAL, Joon-Hyuk PARK, Paul STEGALL
-
Publication number: 20170045442Abstract: A comparative discrimination spectral detection (CDSD) system for the identification of chemicals with overlapping spectral signatures, including: a radiation source for delivering radiation to a sample; a radiation collector for collecting radiation from the sample; a plurality of beam splitters for splitting the radiation collected from the sample into a plurality of radiation beams; a plurality of low-resolution optical filters for filtering the plurality of radiation beams; a plurality of radiation detectors for detecting the plurality filtered radiation beams; and a processor for: receiving a set of reference spectra related to a set of target chemicals and generating a set of base vectors for the set of target chemicals from the set of reference spectra, wherein the set of base vectors define a geometrical shape in a configuration space; receiving a set of filtered test spectra from the plurality of radiation detectors and generating a set of test vectors in the configuration space from the set of filteType: ApplicationFiled: December 11, 2015Publication date: February 16, 2017Applicant: The University Of North Carolina At CharlotteInventors: Menelaos K. Poutous, Ishwar D. Aggarwal, Kevin J. Major, Jas S. Sanghera, Ken Ewing
-
Publication number: 20170047709Abstract: This invention generally relates to a method of controlling emission wavelength of a light emitting device, and a system for wavelength control of a light emitting device, for example for wavelength stabilisation of a laser diode. One method of controlling emission wavelength of a light emitting device comprises: determining an indication of series resistance of the device, the series resistance comprising ohmic resistance of the device; providing a current through the device to maintain light emission of the device; measuring a forward voltage of the device during said light emission, the forward voltage being across an impedance comprising impedance of an active region of the device and the series resistance; determining an indicator of active region voltage on the basis of the measured forward voltage and the determined indicator of series resistance; and controlling a temperature of the device on the basis of the determined indicator of active region voltage.Type: ApplicationFiled: April 9, 2015Publication date: February 16, 2017Applicant: Cranfield UniversityInventors: Elizabeth Jane Hodgkinson, Ralp Peter Tatam, c/o Abdullah Shah Asmari
-
Patent number: 9568366Abstract: A multidimensional spectrometer encodes frequency information into laser pulses so that a frequency insensitive detector may be used to collect data for a multi-dimensional spectrograph only from intensity information and knowledge of a modulation providing the encoding. In one embodiment the frequency encoding may be done by a conventional interferometer greatly simplifying construction of the spectrometer.Type: GrantFiled: May 15, 2015Date of Patent: February 14, 2017Assignees: Wisconsin Alumni Research Foundation, University of ZurichInventors: Martin Thomas Zanni, Peter Hamm, Jan Helbing
-
Patent number: 9570652Abstract: An LED is provided. The LED includes at least two light emitting units located on a same plane. Each light emitting unit includes a first semiconductor layer, an active layer and a second semiconductor layer stacked in that order. Each light emitting unit further includes a first electrode and a second electrode electrically connected with the first semiconductor layer and the second semiconductor layer respectively. The active layer of each light emitting unit is spaced from the active layers of other light emitting units. A distance between adjacent active layer ranges from 1 micron to 1 millimeter.Type: GrantFiled: December 27, 2012Date of Patent: February 14, 2017Assignees: Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.Inventors: Yuan-Hao Jin, Qun-Qing Li, Shou-Shan Fan
-
Patent number: 9566347Abstract: The present invention includes a method of modulating the phagocytic activity of at least one phagocyte in a subject. The present invention also includes a method of providing a composition resistant to phagocytosis to a subject. The present invention further includes a method of treating, ameliorating or preventing an inflammatory disease in a subject.Type: GrantFiled: February 7, 2012Date of Patent: February 14, 2017Assignee: The Trustees of the University of PennsylvaniaInventors: Dennis E. Discher, Pia L. Rodriguez Nunez, Diego A. Pantano
-
Patent number: 9569978Abstract: A computer-implemented method includes selecting, by a virtual problem-based learning (PBL) system, information indicative of a medical profile of a patient; accessing, by the virtual PBL system, information indicative of a team of students using the virtual PBL system; generating, by the virtual PBL system and based on the medical profile, an medical PBL schema comprising a medical problem to be solved by the team of students; generating a plurality of sections in the medical PBL schema, with each section promoting solving of the medical problem, and with each section associated with (i) a private work environment for a student to privately analyze the medical problem, and (ii) a shared, anonymous work environment for the students to view analysis performed by other students in solving the medical problem; and transmitting, to one or more client systems used by the students participating in the virtual problem-based learning system, the medical PBL schema.Type: GrantFiled: May 1, 2013Date of Patent: February 14, 2017Assignee: Universal Research Solutions, LLCInventor: Ali Adel Hussam
-
Patent number: 9567585Abstract: The present invention provides, among other things, oligonucleotide modulators of human 5?-HT2C receptor (HTR2C) and improved methods and composition for treating HTR2C-related diseases, disorders or conditions based on such modulators. In particular, oligonucleotides modulators according to the invention target specific regions in the Exon V/Intron V junction of the human HTR2C pre-mRNA and drive expression of HTR2C Vb splice isoform, leading to increased generation of non-edited strong HTR2C receptor and enhanced serotonin receptor activity.Type: GrantFiled: November 9, 2012Date of Patent: February 14, 2017Assignees: Shire Human Genetic Therapies, Inc., University of KentuckyInventors: Stefan Stamm, Manli Shen, Serene Josiah
-
Patent number: 9568741Abstract: A method of optimising at least one measure that is a quadratic function of a wavefunction, such as the spot size of a laser, the method comprising: superimposing a plurality of wavefunctions; determining a relationship between the superimposed wavefunctions and the quadratic measure, and using the determined relationship to identify the superimposed wavefunctions that provide a desired or optimised quadratic measure.Type: GrantFiled: April 13, 2011Date of Patent: February 14, 2017Assignee: University Court of The University of St AndrewsInventors: Kishan Dholakia, Jorg Baumgartl, Michael Mazilu, Anna Chiara De Luca
-
Patent number: 9566255Abstract: Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.Type: GrantFiled: November 7, 2013Date of Patent: February 14, 2017Assignee: The University of Tennessee Research FoundationInventors: Charles Ryan Yates, Jena Steinle Smith, Duane Douglas Miller, Jordan J. Toutounchian
-
Patent number: 9566241Abstract: Stable nanoparticle compositions comprising buprenorphine and at least one biodegradable polymer. The disclosure also provides methods of controlling pain in an animal and methods of treating addiction in a human utilizing the stable nanoparticle compositions, as well as pharmaceutical formulations comprising the stable nanoparticle compositions. The stable nanoparticle compositions are capable of releasing buprenorphine over several days, weeks, or months following administration. The stable nanoparticle compositions of buprenorphine utilize biodegradable polymers capable of degrading into non-toxic components in the body of an animal and may be excreted in the urine of the animal following their metabolism in the body. The stable nanoparticle compositions can advantageously provide sustained release of buprenorphine in the body after a single administration without the need for surgical removal of implanted matrices subsequent to depletion of the drug.Type: GrantFiled: February 21, 2013Date of Patent: February 14, 2017Assignee: Auburn UniversityInventors: William R. Ravis, Yuh-Jing Lin
-
Patent number: 9569958Abstract: A method for prioritizing events on an electrical power system, including: (a) acquiring at least one data portion representative of the behavior of the electrical power system, the at least one data portion containing at least one power system event; (b) assigning at least one rank value to the at least one data portion based on the type of power system event, the rank value indicative of a priority of the event; and (c) conducting subsequent operations on the at least one data portion in accordance with the at least one rank value.Type: GrantFiled: February 15, 2008Date of Patent: February 14, 2017Assignee: The Texas A&M University SystemInventors: Karthick Muthu-Manivannan, Carl L. Benner, Peng Xu, Billy Don Russell
-
Patent number: 9567291Abstract: This disclosure relates to N-(4-(bis(4-(dimethylamino)phenyl)methylene)-8 -(dimethylamino)naphthalen-1(4H)-ylidene)-N-methylmethanaminium, derivatives, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula I. In certain embodiments, the disclosure relates to methods of treating or preventing Nox related diseases and conditions comprising administering an effective amount of compounds disclosed herein to a subject in need thereof. In certain embodiments, the Nox related disease or condition is cancer.Type: GrantFiled: April 25, 2014Date of Patent: February 14, 2017Assignee: Emory UniversityInventor: Jack Arbiser